Sara Bruce Wirta

Sara Bruce Wirta is an experienced epidemiology director currently at Sobi - Swedish Orphan Biovitrum AB since March 2023. Previously, Sara held several key positions at Novartis Oncology, including Director of RWE & Data Science, where responsibilities encompassed innovative real-world evidence (RWE) generation and strategic data analysis. Sara’s background includes positions as Senior EMEA HEMAR manager at Janssen Inc., and RWE scientist roles at Novartis, focusing on cardio-metabolic research and market access strategy. With a robust foundation in genomics and health economics, Sara has contributed to significant research initiatives during tenure at Karolinska Institutet and gained consulting experience at IMS Health. Sara holds multiple degrees in genetics and molecular biology from Karolinska Institutet, Umeå University, and Lund University.